Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis

This study has been completed.
Sponsor:
Collaborator:
Kansas City Area Life Sciences Institute, Inc.
Information provided by (Responsible Party):
Nancy Hammond, MD, University of Kansas Medical Center Research Institute
ClinicalTrials.gov Identifier:
NCT00490906
First received: June 21, 2007
Last updated: January 17, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)